Company Directory / Biotechnology

Public · NYSE:NVTAFor profitBiotechnologySan Francisco, CA, United States
Invitae is a medical genetics company that bring comprehensive genetic information into mainstream medicine to improve healthcare.
Invitae, now part of Labcorp, is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We’re working to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of our mission to bring comprehensive genetic information into mainstream medicine to improve… Read all
Invitae, now part of Labcorp, is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We’re working to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of our mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Within each of us lies information coded in our DNA that can transform our health. Unlocking that potential requires highly specialized, multidisciplinary collaboration. Our world-class genetics experts drive the development of a highly complex system of tools and processes, including robotics, artificial intelligence, machine learning, and software engineering. All of this comes together to provide patients with accurate, reliable results that can help guide decisions across the healthcare journey and potentially change lives today and for the next generation. Our teammates are grounded in a universal sense of urgency and ownership. We believe in the team above the individual and celebrate freedom with accountability. Employees are encouraged to speak up, try new things and make decisions that push us forward. We provide all Invitaens with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. At Invitae, we're putting patients' genetic insights where they belong, at the center of healthcare. And we're doing it together, with you. Join us.
Size
1001-5000 people: larger than 97% of companies with a size listed. 861 people list it on LinkedIn.
Age
16 years old.
Reach
Website ranked #123,834 in the world for traffic, about 406k visits a month. 146,243 followers on LinkedIn.
BiotechnologyGeneticsHealth Caregenomicsbiotechnologyhealthcareoncologycancercardiologyrare genetic diseaseneurologyhematologypediatric geneticsgenetic testing
Funding, as listed
$2.7B raised in total
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Everything the source datasets list about Invitae, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Invitae has filed for Chapter 11 bankruptcy, citing ill-timed deals and falling demand as primary reasons. The company is preparing for a sale, and Labcorp has won a $239 million bid for Invitae's assets, including a significant site in the Triangle area.
Summaries written by the source dataset, not by us, and not checked.
Biotechnology in United States.
InsmedBridgewater Township · 501-1000 people · 51k followersSSAGE TherapeuticsCambridge · 501-1000 people · 111k followers
Amicus TherapeuticsPrinceton · 501-1000 people · 48k followers
GrailMenlo Park · 1001-5000 people
PacBioMenlo Park · 501-1000 people · 85k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.